Associated Papers
Upregulation versus loss of function of NTRK2 in 44 affected individuals leads to 2 distinct neurodevelopmental disorders.
Berger E et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2025
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Gudernova I et al.
Oncotarget, 2017
Select a paper to view details